Johnson & Johnson New Skin Care Products

Johnson & Johnson New Skin Care Products 2010

Johnson & Johnson launched new products based on completely new technologies 2010 for three of their brands. They are Aveeno Active Naturals Ageless Vitality Elasticity Recharging System, Neutrogena Clinical, and RoC Brilliance. The technology behind these new products is a two-part system containing ion-mineral conductors that, when activated by the companion moisturizer, create a positive electric micro-current on the skin, which, supposedly, promotes collagen and elastin levels.

It is quite complicated to present the whole idea behind this new technology. In short, (1) this concept is biologically plausible; (2) there is no independent research supporting it; (3) company sponsored researches have been presented in annual meetings of the American Academy of Dermatology, which showed impressive results demonstrating its effectiveness.

The human body is a bio-electrical system, including the skin. The concept of "skin battery" has been dated back to the 1980s. Since then, there have been a lot of researches on electrical stimulation, mainly for the treatment of skin wounds. In 2007 annual meeting of the American Academy of Dermatology, a research sponsored by Obagi demonstrated the effectiveness of a bi-mineral complex in improving photo-aged skin. They believe that some coordination minerals, such as copper and zinc, can thicken skin, improve elasticity, and increase the subcutaneous fat layer. I am surprised that Obagi did not patent this big finding (they did have a prescription-only product called ELASTIderm including the zinc and copper complex). The giant, Johnson & Johnson, instead, has worked over 2.5 years, evaluating this technology on more than 1,000 individuals/subjects in clinical and safety studies. And now they hold 10 U.S. patents active until 2023 and has multiple U.S. and international applications pending!

In 2010 annual meeting of the American Academy of Dermatology, Johnson & Johnson presented the effectiveness of their bi-mineral complex in anti-inflammatory activity, extracellular matrix production in human skin explants, improvement of pigmentation, photo-aging and improvement of skin laxity. They got so much attention! Apparently, products based on this new technology have a strength in terms of skin tolerance. This means that it can be used for eyelids and skin around the eye area. Considering retinoid and AHA products often have a label "Avoid Eye Area", these new products are very promising.

Some reviewers suspect that Johnson & Johnson uses two-step systems just to make more money. I never talked with anyone working on this, asking them why they used two-step systems. But from how I understand this, I think a two-step system is very plausible. The zinc and copper should be stable in the first-step gel. Then you apply the second-step cream, which performs as a conductor to activate the exchange of electrons. If they put everything together in one bottle, then zinc and copper has already exchanged electrons before you apply them. So I think a two-step system is a smart way to make this process effective on your skin.

Now, after all the excitement about this new technology, I do have one concern. I hope that Johnson & Johnson will answer it some day. How will these products affect the skin's own bio-electrical activity? Once I stop using them, will my skin's natural bio-electrical activity be paralyzed and my skin turn worse?

Monday, July 19, 2010

JNJ: Johnson & Johnson's Stock Returns Reveiwed

Most of us use some form of Johnson & Johnson's products regularly in our daily life. Tylenol, Band-Aid, Motrin, and Listerine are some of the many trademarked products offered by Johnson and Johnson (JNJ). As a result of its household practicality and deeply ingrained name recognition, JNJ has also been a very popular stock holding. Fortunately, for shareholders, it has performed very well over the last quarter century. In fact, $10,000 invested in Johnson & Johnson at the beginning of 1975 would have grown to over $391,000 at the end of 2006, not even including any dividends or spinoffs that may have occurred.

Since 1975, Johnson & Johnson has had 22 years of positive returns and 10 years of negative returns. The best returning years for JNJ stock were 1991, 1995, and 1985, earning 60%, 56%, and 46% respectively. Conversely, the worst performing years for JNJ stock were 1983, 1976, and 1993, with the losses for the year being 18%, 13%, and 12% respectively. The growth of Johnson & Johnson's stock over the last quarter century has resulted in five stock splits with the last one being a 2 for 1 split in June of 2001.

Johnson & Johnson is one of the 30 stocks that make up the Dow Jones Industrial Average (DJIA). However, JNJ's yearly returns are not as closely correlated with the overall DJIA movements as other stocks in the widely followed index. For example, General Electric (GE), has moved in the same direction of the Dow Jones nearly 94% of the time since 1975. Johnson & Johnson, on the other hand, has moved in the same direction as the DJIA a little under 72% of the time during that same time period. In fact, 9 of the 32 years since 1975, JNJ has moved in the opposite direction of the overall Dow Jones Industrial Average. Moving forward, I expect Johnson & Johnson to continue to steadily grow in the future as the usage of its dominant brand name products continue to grow along with the population. Of course, as always, do your own due diligence before making any investment decisions.

Johnson & Johnson Case Study

NICORETTE brand manager at Johnson & Johnson, Rob Elliott has learned the value of having his leaflets in doctors surgeries throughout the UK.

Positive feedback from IDS proves patients are picking up the Need Help to Stop Smoking leaflets in their droves – and as a result discussing life-changing advice on giving-up cigarettes with a health care professional.

“It's good to know that we are getting a good response from patients who pick up our leaflets.

“We do a great deal of market research with healthcare professionals, patients and consumers– but the information we get from IDS concerns people who have actually picked up one of our leaflets and have completed a questionnaire,” he said.

Every company using the Waiting room Information Service receives a detailed marketing report from IDS pinpointing information about their leaflets.

The report on the Need to Stop Smoking leaflet showed:

Over half of those taking the leaflet sought further advice
(This was mainly from healthcare professionals)
Half received a prescription as a result of reading the leaflet
Over half will or have made a purchase as a result of the leaflet
(Mainly from pharmacies)

In total 582 people who had selected the Need to Stop Smoking leaflet responded to the IDS questionaire – that represents 15% of all people returning a questionnaire in the past 12 months.

Feedback from the questionnaire was both quantitative and qualitative with comments that endorsed the campaign.

“The leaflet caught my eye when I was at the doctor's so you know there is help available. I picked it up and gave it to my husband and he went to the doctor and asked for help. He has given up now and is doing well,” said one respondent.

And another commented: “Without seeing the leaflet we would never have considered asking the doctor about giving up smoking – it is a very,very good service to have this information available to patients so that you can look at it and then ask the doctor when you go in.”

Responses to the questionnaire showed that often people will be visiting their doctor for another ailment – and while waiting to see their GP, they will pick up a leaflet and discuss it with their doctor.

“We were staying with friends and he [my husband] was taken bad not being able to breathe so we went to her doctor's and while we were waiting we saw the leaflet about help to give up smoking.

“So when we went in to see the doctor about the breathing problem, we asked him about getting nicorette patches,” explained another respondent.

Ultimately the research proved WIS:

Delivers effectively and consistently to those for whom it is relevant
And often drives them to seek further advice, notably from the healthcare professionals
This in turn, leads to prescriptions and to products being purchased

Rob Elliot added: “I would recommend the service – I've had first hand experience on field visits that our leaflets are pretty well used.

“Once you get the design right, you will get people picking up the leaflet. It means that people who are thinking about giving up smoking but may have an appointment to speak about a different matter, will bring this up as a result of seeing the leaflets.

“And they will take the leaflets for family members and friends – meaning the information is getting out to a wider community.”

Business Development Manager Sarah O'Reilly said she was delighted with Rob's comments and it showed the power of the Waiting room Information Service.

A Description of the Vistakon, a Division of Johnson & Johnson

Johnson & Johnson is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. The Vistakon is a division of Johnson & Johnson Vision Care, Inc, which specializes in producing disposable contact lenses. ACUVUE, HYDRACLEAR, ASTIGMATISM and ADVANCE, etc. are brand names that sell different disposable contact lenses under the Vistakon.

Different products of Acuvue series are equipped with different features, that applicable to different needs of different people. Let's take Acuvue Oasys for example:

Acuvue Oasys contact lens specially works for dry eyes. With it, a wearer feels fresh and comfortable even without removal, cleanness and storage for several days. What is more, Acuvue Oasys applies a unique technology helping to make the structure more stable and leveraging the natural pressure between eyelids. Therefore, when eyeball moves, the lens is able to keep firm on the eyeball, no discomfort caused.

The fact is not only Acuvue Oasys has the property of moist retain, all the Acuvue family have the same alike property. Why? Because their basic component is senofilcon A, or say silicone hydro gel. It is a newly emerged generation, not only keeping moisture, but also providing the users a comfortable, silky feel. This is why many people who have ever worn Acuvue would state that Acuvue contact lenses escape them from tired eyes.

Besides the property of moisture retaining, the ability of oxygen permeability is greatly enhanced, which is rather helpful for the eye health. This is also one of the reasons why Acuvue family contacts specially work for dry eyes and tired eyes.

The feature of UV protection can be found in the astigmatism range of lenses, which is supposed to block more than 96% and 99% of UVB and UVA rays. This should be the maximum protection from UV rays of contact lenses as that of sunglasses.

Owing to all those distinctive features and technology, Acuvue product is a hot seller in the market.

Firmoo.com is the fastest growing online community selling high quality yet cheap prescription eyeglasses, prescription sunglasses online and other eyewear. Firmoo's return and refund policy makes your purchase with Firmoo risk-free.

search box